231 related articles for article (PubMed ID: 28438506)
1. Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8
Andrada E; Liébana R; Merida I
EBioMedicine; 2017 May; 19():39-48. PubMed ID: 28438506
[TBL] [Abstract][Full Text] [Related]
2. Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes.
Arranz-Nicolás J; Martin-Salgado M; Rodríguez-Rodríguez C; Liébana R; Moreno-Ortiz MC; Leitner J; Steinberger P; Ávila-Flores A; Merida I
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33246984
[TBL] [Abstract][Full Text] [Related]
3. DGKζ exerts greater control than DGKα over CD8
Gu J; Wang C; Cao C; Huang J; Holzhauer S; Desilva H; Wesley EM; Evans DB; Benci J; Wichroski M; Wee S; Riese MJ
Oncoimmunology; 2021; 10(1):1941566. PubMed ID: 34350062
[TBL] [Abstract][Full Text] [Related]
4. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells.
Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I
Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304
[TBL] [Abstract][Full Text] [Related]
5. Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses.
Riese MJ; Grewal J; Das J; Zou T; Patil V; Chakraborty AK; Koretzky GA
J Biol Chem; 2011 Feb; 286(7):5254-65. PubMed ID: 21138839
[TBL] [Abstract][Full Text] [Related]
6. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.
Riese MJ; Wang LC; Moon EK; Joshi RP; Ranganathan A; June CH; Koretzky GA; Albelda SM
Cancer Res; 2013 Jun; 73(12):3566-77. PubMed ID: 23576561
[TBL] [Abstract][Full Text] [Related]
7. T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.
Jing W; Gershan JA; Holzhauer S; Weber J; Palen K; McOlash L; Pulakanti K; Wesley E; Rao S; Johnson BD; Riese MJ
Cancer Res; 2017 Oct; 77(20):5676-5686. PubMed ID: 28916658
[TBL] [Abstract][Full Text] [Related]
8. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
[TBL] [Abstract][Full Text] [Related]
9. TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β.
Arumugam V; Bluemn T; Wesley E; Schmidt AM; Kambayashi T; Malarkannan S; Riese MJ
J Leukoc Biol; 2015 Nov; 98(5):703-12. PubMed ID: 26153417
[TBL] [Abstract][Full Text] [Related]
10. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.
Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA
Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043
[TBL] [Abstract][Full Text] [Related]
11. Diacylglycerol kinases in cancer.
Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
[TBL] [Abstract][Full Text] [Related]
12. Unexpected positive control of NFκB and miR-155 by DGKα and ζ ensures effector and memory CD8+ T cell differentiation.
Yang J; Zhang P; Krishna S; Wang J; Lin X; Huang H; Xie D; Gorentla B; Huang R; Gao J; Li QJ; Zhong XP
Oncotarget; 2016 Jun; 7(23):33744-64. PubMed ID: 27014906
[TBL] [Abstract][Full Text] [Related]
13. Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
Arranz-Nicolás J; Martin-Salgado M; Adán-Barrientos I; Liébana R; Del Carmen Moreno-Ortíz M; Leitner J; Steinberger P; Ávila-Flores A; Merida I
Cancer Immunol Immunother; 2021 Nov; 70(11):3277-3289. PubMed ID: 33837851
[TBL] [Abstract][Full Text] [Related]
14. Diacylglycerol kinase ζ limits the polarized recruitment of diacylglycerol-enriched organelles to the immune synapse in T cells.
Andrada E; Almena M; de Guinoa JS; Merino-Cortes SV; Liébana R; Arcos R; Carrasco S; Carrasco YR; Merida I
Sci Signal; 2016 Dec; 9(459):ra127. PubMed ID: 27999176
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases.
Shin J; O'Brien TF; Grayson JM; Zhong XP
J Immunol; 2012 Mar; 188(5):2111-7. PubMed ID: 22271650
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of diacylglycerol and ERK-mediated signaling differentially controls CD8
Harabuchi S; Khan O; Bassiri H; Yoshida T; Okada Y; Takizawa M; Ikeda O; Katada A; Kambayashi T
Front Immunol; 2022; 13():1032113. PubMed ID: 36846018
[TBL] [Abstract][Full Text] [Related]
17. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
Takao S; Akiyama R; Sakane F
J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248
[TBL] [Abstract][Full Text] [Related]
18. Negative control of diacylglycerol kinase ζ-mediated inhibition of T cell receptor signaling by nuclear sequestration in mice.
Xie D; Zhang S; Chen P; Deng W; Pan Y; Xie J; Wang J; Liao B; Sleasman JW; Zhong XP
Eur J Immunol; 2020 Nov; 50(11):1729-1745. PubMed ID: 32525220
[TBL] [Abstract][Full Text] [Related]
19. Enhanced T cell responses due to diacylglycerol kinase zeta deficiency.
Zhong XP; Hainey EA; Olenchock BA; Jordan MS; Maltzman JS; Nichols KE; Shen H; Koretzky GA
Nat Immunol; 2003 Sep; 4(9):882-90. PubMed ID: 12883552
[TBL] [Abstract][Full Text] [Related]
20. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
Linch SN; Kasiewicz MJ; McNamara MJ; Hilgart-Martiszus IF; Farhad M; Redmond WL
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E319-27. PubMed ID: 26729864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
